TY  - BOOK
AU  - Huang, Chun Chih
AU  - Scott, Rachel K
TI  - Universal Rapid Human Immunodeficiency Virus Screening at Delivery: A Cost-Effectiveness Analysis
SN  - 1064-7449
PY  - 2018///
KW  - *HIV Infections/di [Diagnosis]
KW  - *Infectious Disease Transmission, Vertical/pc [Prevention & Control]
KW  - *Mass Screening/ec [Economics]
KW  - *Mass Screening/mt [Methods]
KW  - Adolescent
KW  - Adult
KW  - Cost-Benefit Analysis
KW  - Female
KW  - HIV Infections/ec [Economics]
KW  - Humans
KW  - Incidence
KW  - Middle Aged
KW  - Pregnancy
KW  - Prevalence
KW  - Quality-Adjusted Life Years
KW  - United States/ep [Epidemiology]
KW  - Young Adult
KW  - MedStar Health Research Institute
KW  - Journal Article
N1  - Available online from MWHC library: 1998 - present
N2  - Conclusions: Intrapartum universal rapid HIV screening to decrease MTCT appears cost-effective in populations with high HIV incidence in the United States; Objective: To determine the cost-effectiveness of universal maternal HIV screening at time of delivery to decrease mother-to-child transmission (MTCT), by comparing the cost and quality-adjusted life years (QALYs) of universal rapid HIV screening at time of delivery to two current standards of care for prenatal HIV screening in the United States; Results: The incremental cost-effectiveness ratio for universal screening was; Study Design: We conducted a cost-effectiveness analysis to compare the cost and QALY of universal intrapartum rapid HIV screening with two current standards of care: (I) opt-out rapid HIV testing limited to patients without previous third-trimester screening and (II) opt-out rapid HIV testing limited to patients without any prenatal screening. We developed a decision-tree model and performed sensitivity analyses to estimate the impact of variances in QALY, estimated lifetime medical costs, HIV prevalence, and cumulative incidence
UR  - https://dx.doi.org/10.1155/2018/6024698
ER  -